Takeda Pulls FDA Application for Expanded Use of Cancer Drug VelcadeGenetic Engineering NewsMillennium: The Takeda Oncology Company has decided to withdraw its sNDA for Velcade in combination with rituximab for the treatment of relapsed follicular lymp…
iBio announces production of biosimilar rituximab drug, shares rallyProactive Investors UKiBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technology has been used to produce a functional,…
TopNews New ZealandJonah Lomu Approved of Kidney TransplantationTopNews New ZealandJonah Lomu will be undergoing another Kidney transplantation surgery as his earlier transplantation has failed to work. The rugby player had undergone the transplantatio…
Robotic versus laparoscopic partial nephrectomy for bilateral synchronous …UroTodayThe median warm ischemia time was shorter in the RPN group than in the LPN group (19 vs 37 minutes, respectively; P = .059). The median tumor size was 2.85 and 2.7 cm …
Proactive Investors USA & CanadaiBio announces production of biosimilar rituximab drug, shares rallyProactive Investors USA & CanadaiBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technol…
iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ TechnologySacramento BeeRituximab is a chimeric mouse-human monoclonal antibody that binds to the CD20 antigen presented on the B-cell surface. Scientists at iBio's research a…
Voclosporin study published in the American Journal of TransplantationCanada NewsWire (press release)The primary endpoint of the study was to demonstrate noninferiority of at least one of the three VCS groups in preventing acute rejection compared to T…
iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ TechnologyPR Newswire (press release)… production of biotherapeutic proteins and vaccine antigens in whole green plants has been used to produce a functional monoclonal antibody…
MedIndiaComplications of Chronic Kidney Disease Occur Earlier in ChildrenKansas City infoZineWashington, DC – infoZine – In what may lead to a shift in treatment, the largest prospective study of children with chronic kidney disease (CKD) has confirmed…
InPharmMerck KGaA signs MS and cancer research dealInPharmIn August Biogen and Abbott's MS drug daclizumab, a new injectable, performed well in a Phase IIb study, although two deaths marred the overall results. But Novartis' oral drug Gilenya (…